EISSN 2757-6256

TAP is categorized as Q2 in JIF. SCOPUS CITESCORE: 2.4 TAP IS INDEXED IN PUBMED

Turkish Archives of Pediatrics

60 144 2025

HIGHLY CITED ARTICLES

Revisiting Childhood-Onset Systemic Lupus Erythematosus

Avar-Aydın and Brunner.

Familial Mediterranean Fever in Childhood

Kisla Ekinci et al.

Artificial Intelligence in Pediatrics: Learning to Walk Together

Demirbaş et al.

Infant and Young Child Feeding in Emergencies: A Narrative Review

Bilgin et al.

Differentiating Multisystem Inflammatory Syndrome in Children from Kawasaki Disease During the Pandemic

Şener et al.

Vasculitis in Children

Bayındır et al.

Graphical Abstract

Scientific Letters

Emapalumab as a Life-Saving Therapy for Macrophage Activation Syndrome in Refractory Systemic Juvenile Idiopathic Arthritis with Trisomy 21

Nergis Akay ¹ , Ece Aslan ¹ , Umit Gul ¹ , Elif Kilic Konte ² , Mehmet Yildiz ¹ , Sezgin Sahin ¹

Author Affiliation(s)

1.

Department of Pediatric Rheumatology, İstanbul University-Cerrahpaşa Cerrahpaşa Faculty of Medicine, İstanbul, Türkiye

2.

Department of Pediatric Rheumatology, İstanbul University-Cerrahpaşa Cerrahpaşa Medical Faculty, İstanbul, Türkiye

Turk Arch Pediatr 2025; 60: 695-699

DOI: 10.5152/TurkArchPediatr.2025.25394

Read: 25 Downloads: 10 Published: 03 November 2025

Volume 60, Issue 6, November 2025

Previous Article

Cite this article as: Akay N, Aslan E, Gul U, Konte EK, Yildiz M, Sahin S. Emapalumab as a life-saving therapy for macrophage activation syndrome in refractory systemic juvenile idiopathic arthritis with trisomy 21. Turk Arch Pediatr. 2025;60(6):695-699.

Files